Approaches to Conversations About Long-Acting Injectable Antipsychotics
Image For Activity Cover
Expires on Mar 11, 2027
Credit Offered
1 CME Credit
1 COP Credit

This presentation will guide clinicians in having discussions with patients for whom they recommend consideration of long-acting injectable antipsychotics (LAI). Approaches will be explored for negotiating LAIs as part of a patient’s tailored treatment plan, including benefit/risk analysis and scripts covering frequently encountered questions and situations. Role play will illustrate various relevant scenarios and styles that may be used by clinicians. Lastly, a panel discussion among clinicians with LAI experience will dialogue about LAI implementation practices from the field.


Recorded webinar, non-interactive, self-paced distance learning activity with post-test.

This presentation was recorded on March 11, 2021.

Learning Objectives

  • Guide discussions and of the use of long-acting injectable antipsychotics (LAIs) with patients, including benefits and risks.
  • Utilize prepared scripts for collaborative discussions with patients about LAI options and troubleshooting anticipated patient challenges.
  • Utilize best practices of shared decision making when offering LAIs as a treatment option for appropriate patients. 

Target Audience

Pharmacist, Psychiatrist, Physician (non-psychiatrist), Physician Assistant, Nurse/Nurse Practitioner

Instructional Level


Estimate Time to Complete

Estimated Duration: 1.0 hour
Program Start Date: March 11, 2024 
Program End Date: March 11, 2027

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course, including viewing the full video and submitting an evaluation. A multiple-choice quiz is provided based on the content. A passing score of 75% must be achieved. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (other disciplines) showing the completion date and hours/credits earned.

Continuing Education Credit


The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures


  • Eric Achytes, MD, Michigan State University. Disclosure - Stock: Moderna, Pfizer, Johnson & Johnson, AstraZeneca; Consultant: Alkermes, Roche, Lundbeck, Otsuka, Janssen, Neurocrine Biosciences, Teva, Sunovion; Grant/Research: Alkermes, Astellas, Biogen, Boehringer-Ingelheim, InnateVR, Janssen, Neurocrine Biosciences, Novartis, Otsuka, Pear Therapeutics, Takeda; Employee: Pine Rest Christian Mental Health Services, Cherry Health, Network180.
  • Robert Cotes, MD, Emory University. Disclosure - Consultant: Saladax Biomedical; Grant/Research: Otsuka, Roche, Lundbeck, and Alkermes
  • Sarah MacLaurin, RN, Freedom Trail Clinic. Disclosure - Grant/Research: Janssen, Alkermes
  • Donna Rolin, PhD, APRN, University of Texas at Austin. Reports no financial relationships with commercial interests.


  • Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests.
  • Tristan Gorrindo, MD, American Psychiatric Association. Reports no financial relationships with commercial interests.
  • Donna Rolin, PhD, APRN, University of Texas at Austin. Reports no financial relationships with commercial interests.  
  • Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests. (Reviewed on 1/9/2024)
  • John Torous, MD, MBI, Beth Israel Deaconess Medical Center. Reports no financial relationships with commercial interests. (Reviewed on 1/9/2024

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.

Technical Requirements

This internet-based CME activity is best experienced using any of the following:

  • The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
  • Internet Explorer 11+

This website requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be:  Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
  • Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
  • Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content

For assistance: Contact for questions about this activity | Contact for technical assistance

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Powered By